Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  ConvaTec Group    CTEC   GB00BD3VFW73

CONVATEC GROUP (CTEC)
Mes dernières consult.
Most popular
Report
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed London Stock Exchange
12/06/2017 12/07/2017 12/08/2017 12/11/2017 12/12/2017 Date
207.5(c) 209.7(c) 210.2(c) 213(c) 211.9 Last
6 145 983 6 795 509 11 017 759 8 972 040 1 554 586 Volume
+0.05% +1.06% +0.24% +1.33% -0.52% Change
More quotes
Financials ($)
Sales 2017 1 743 M
EBIT 2017 367 M
Net income 2017 160 M
Debt 2017 1 502 M
Yield 2017 2,03%
Sales 2018 1 834 M
EBIT 2018 402 M
Net income 2018 219 M
Debt 2018 1 265 M
Yield 2018 2,43%
P/E ratio 2017 32,88
P/E ratio 2018 24,03
EV / Sales2017 4,05x
EV / Sales2018 3,73x
Capitalization 5 566 M
More Financials
Company
ConvaTec Group Plc is a holding company engages in medical business.Its activities include development, manufacture and sales of medical products and technologies related to therapies for the management of chronic conditions, including products used for advanced chronic and acute wound care, ostomy... 
Sector
Pharmaceuticals
Calendar
02/28Earnings Release
More about the company
Surperformance© ratings of ConvaTec Group
Trading Rating : Investor Rating :
More Ratings
Latest news on CONVATEC GROUP
12/04 CONVATEC : Organisation Appointments 04 December 2017
12/04 CONVATEC : Organisation Appointments
11/30 A TASTE FOR SUCCESS Online delivery startup Just Eat promoted to the FTSE 100
11/29 Just Eat to join top table of British business
11/07 CONVATEC : stock recovers after UBS upgrade
11/06 Financials dampen FTSE as broker action dominates
11/03 GLOBAL WOUND DEBRIDEMENT PRODUCT MAR : The Wound Debridement Product Market 2017..
10/26 FTSE 100 gets sterling boost while Barclays dives after results
10/20 CONVATEC : chair snaps up more stock after the company's shares drop
10/17 FTSE inches down, Merlin collapses on poor summer trading
More news
Sector news : Specialty & Advanced Pharmaceuticals
11:03aDJMERCK : Appoints Allan Gabor as Managing Director in China
08:42aDJGLAXOSMITHKLINE : Encouraged By Blood-Cancer Drug Study
07:32aDJSANOFI : Receives U.S. FDA Approval for Insulin Injection Admelog
12:56a Monsanto offers cash to U.S. farmers who use controversial chemical
12/11 ASTRAZENECA : GSK's new pharma head on lookout for cancer deals to boost pipelin..
More sector news : Specialty & Advanced Pharmaceuticals
News from SeekingAlpha
10/16 Convatec (CNVVY) Q3 Trading Update - Slideshow
03/31 SNIPPET ROUNDUP : Novartis Meets CAR-T Filing Deadline, Numab Snares Ono
Chart CONVATEC GROUP
Duration : Period :
ConvaTec Group Technical Analysis Chart | CTEC | GB00BD3VFW73 | 4-Traders
Technical analysis trends CONVATEC GROUP
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 13
Average target price 3,02 $
Spread / Average Target 6,3%
EPS Revisions
Managers
NameTitle
Paul Moraviec Chief Executive Officer & Director
Christopher Charles Gent Non-Executive Chairman
Frank M. Schulkes Chief Financial Officer
Robert Steele EVP-Quality, Clinical & Regulatory Affairs
Steven John Holliday Deputy Chairman
Sector and Competitors
1st jan.Capitalization (M$)
CONVATEC GROUP-10.13%5 566
ABBVIE50.50%152 953
MERCK KGAA-10.38%13 516
KYOWA HAKKO KIRIN CO LTD31.58%10 547
JAZZ PHARMACEUTICALS PLC23.66%8 331
ZHANGZHOU PIENTZEHUANG PHARMACEUTICL LTD37.43%5 735